Purapharm Corp. Ltd. | Income Statement
Fiscal year is January-December. All values HKD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
342,303.00
366,352.00
473,900.00
535,986.00
591,566.00
745,503
Cost of Goods Sold (COGS) incl. D&A
131,969.00
144,239.00
168,882.00
187,814.00
196,556.00
291,251
Gross Income
210,334.00
222,113.00
305,018.00
348,172.00
395,010.00
454,252
SG&A Expense
172,768.00
170,206.00
239,877.00
307,749.00
397,892.00
446,373
EBIT
35,149.00
55,570.00
70,708.00
48,203.00
2,882.00
7,879
Unusual Expense
-
-
18,999.00
-
9,102.00
26,873
Non Operating Income/Expense
7,435.00
890.00
2,165.00
915.00
11,773.00
13,227
Interest Expense
13,149.00
13,064.00
10,243.00
9,331.00
16,867.00
21,879
Pretax Income
29,690.00
42,330.00
40,134.00
38,667.00
10,331.00
26,531
Income Tax
3,399.00
7,823.00
11,676.00
6,505.00
8,442.00
5,725
Consolidated Net Income
26,291.00
34,507.00
28,458.00
32,162.00
1,889.00
20,806
Net Income
26,264.00
34,463.00
28,458.00
32,162.00
1,889.00
20,806
Net Income After Extraordinaries
26,264.00
34,463.00
28,458.00
32,162.00
1,889.00
20,806
Net Income Available to Common
26,264.00
34,463.00
28,458.00
32,162.00
1,889.00
20,806
EPS (Basic)
0.12
0.15
0.15
0.14
0.01
0.08
Basic Shares Outstanding
225,000.00
225,000.00
195,873.30
223,444.60
237,974.90
244,981.70
EPS (Diluted)
0.12
0.15
0.15
0.14
0.01
0.08
Diluted Shares Outstanding
225,000.00
225,000.00
195,873.30
223,444.60
239,092.60
246,509
EBITDA
47,194.00
69,156.00
83,935.00
64,744.00
23,954.00
45,175
Other Operating Expense
2,417.00
3,663.00
5,567.00
7,780.00
-
-
Non-Operating Interest Income
255.00
714.00
833.00
710.00
450.00
431
Minority Interest Expense
27.00
44.00
-
-
-
-
About Purapharm Corp.
View Profile
